It's amazing that they are doing $200m on 170 customers, but, just to raise it - there aren't that many big pharma companies out there. So what does that say about their future growth?
I do a lot of Veeva applications for healthcare. It's pretty interesting and almost all of our clients are really into it right now. I'd say 50 percent of our work is related to Veeva. If anyone has any questions about it I can answer some.<p>To add to this a bit. One of the main reasons it is doing so well is that their clients (healthcare) are willing to spend ridiculous amounts of money on software. They emphasize that Veeva only has 170 customers, but these customers are people like <insert giant pharma name here>. It's not like their customers are some mom and pop shops.<p>It is nice to see healthcare trying out new things. Typically they are a few years behind on the curve due to their demographic.